Patrik Krumpolec
Overview
Explore the profile of Patrik Krumpolec including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
245
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Acute and regular exercise distinctly modulate serum, plasma and skeletal muscle BDNF in the elderly
Maderova D, Krumpolec P, Slobodova L, Schon M, Tirpakova V, Kovanicova Z, et al.
Neuropeptides
. 2019 Sep;
78:101961.
PMID: 31506171
Brain-derived neurotrophic factor (BDNF) participates in orchestrating the adaptive response to exercise. However, the importance of transient changes in circulating BDNF for eliciting whole-body and skeletal muscle exercise benefits in...
12.
Gajdosik M, Hingerl L, Skoch A, Freudenthaler A, Krumpolec P, Ukropec J, et al.
J Magn Reson Imaging
. 2018 Dec;
50(1):71-82.
PMID: 30578581
Background: Omega-3 (n-3) fatty acids (FA) play and important role in neural development and other metabolic diseases such as obesity and diabetes. The knowledge about the in vivo content and...
13.
Pfleger L, Gajdosik M, Wolf P, Smajis S, Fellinger P, Kuehne A, et al.
J Magn Reson Imaging
. 2018 Oct;
49(2):597-607.
PMID: 30291654
Background: Hepatic disorders are often associated with changes in the concentration of phosphorus-31 ( P) metabolites. Absolute quantification offers a way to assess those metabolites directly but introduces obstacles, especially...
14.
Krumpolec P, Vallova S, Slobodova L, Tirpakova V, Vajda M, Schon M, et al.
Front Neurol
. 2018 Jan;
8:698.
PMID: 29312123
Clinical Trial Registration: www.ClinicalTrials.gov, identifier NCT02253732.
15.
Baye E, Ukropec J, de Courten M, Vallova S, Krumpolec P, Kurdiova T, et al.
Sci Rep
. 2017 Dec;
7(1):17458.
PMID: 29234057
Carnosine has been shown to reduce oxidation and glycation of low density lipoprotein hence improving dyslipidaemia in rodents. The effect of carnosine on human plasma lipidome has thus far not...
16.
Heckova E, Povazan M, Strasser B, Krumpolec P, Hnilicova P, Hangel G, et al.
Radiology
. 2017 Sep;
286(2):666-675.
PMID: 28957645
Purpose To compare the involuntary head motion, frequency and B shim changes, and effects on data quality during real-time-corrected three-dimensional γ-aminobutyric acid-edited magnetic resonance (MR) spectroscopic imaging in subjects with...
17.
Stanikova D, Buzga M, Krumpolec P, Skopkova M, Surova M, Ukropcova B, et al.
PLoS One
. 2017 May;
12(5):e0177222.
PMID: 28472148
Background: Inactivating mutations of the hypothalamic transcription factor singleminded1 (SIM1) have been shown as a cause of early-onset severe obesity. However, to date, the contribution of SIM1 mutations to the...
18.
Regazzoni L, de Courten B, Garzon D, Altomare A, Marinello C, Jakubova M, et al.
Sci Rep
. 2016 Jun;
6:27224.
PMID: 27265207
Carnosine is a natural dipeptide able to react with reactive carbonyl species, which have been recently associated with the onset and progression of several human diseases. Herein, we report an...
19.
de Courten B, Jakubova M, de Courten M, Kukurova I, Vallova S, Krumpolec P, et al.
Obesity (Silver Spring)
. 2016 Apr;
24(5):1027-34.
PMID: 27040154
Objective: Carnosine is a naturally present dipeptide in humans and an over-the counter food additive. Evidence from animal studies supports the role for carnosine in the prevention and treatment of...
20.
Balaz M, Ukropcova B, Kurdiova T, Vlcek M, Surova M, Krumpolec P, et al.
Adipocyte
. 2015 Jul;
4(2):113-22.
PMID: 26167410
Growth hormone (GH) supplementation therapy to adults with GH deficiency has beneficial effects on adipose tissue lipid metabolism, improving thus adipocyte functional morphology and insulin sensitivity. However, molecular nature of...